Cargando…
Effectiveness and safety of immune checkpoint inhibitors: A retrospective study in Taiwan
BACKGROUND: Since 2012, several immune checkpoint inhibitors have been approved by the Taiwan FDA for various types of cancer treatment. However, none of them are covered by Taiwan National Health Insurance due to the fact that they are expensive, and there is a lack of clinical evidence as to their...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6108484/ https://www.ncbi.nlm.nih.gov/pubmed/30142174 http://dx.doi.org/10.1371/journal.pone.0202725 |